What are the administration methods and usage of irinotecan hydrochloride liposome injection?

This drug is administered by intravenous drip, and the dose is generally calculated based on the patient's body surface area. The initial dose and subsequent medication regimen will be formulated by the attending physician based on the patient's specific condition, weight, liver and kidney function, and previous treatment response. The infusion time of liposome preparations is usually longer than that of traditional irinotecan, usually taking several hours to complete, to reduce infusion-related reactions. The treatment cycle is usually once every 2 to 3 weeks. The specific plan is adjusted according to the patient's tolerance and efficacy. Vital signs need to be closely monitored during administration to prevent acute adverse reactions. Before treatment, the doctor should be informed of all medications to avoid drug interactions.